Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer

• VANSTEENKISTE J

収録刊行物

• J Clin Oncol Suppl

  J Clin Oncol Suppl 25 398s-, 2007

詳細情報

• CRID: 1570009750950219648
• NII論文ID: 10025557722
• データソース種別:
  • CiNii Articles